Back to companies

Sun Pharmaceutical Industries Ltd: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company that offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s portfolio includes products for the treatment of psychiatric, neurological, nephrological, gastroenterological, orthopedic and ophthalmologic diseases and disorders, and heart diseases. The company carries out product development, process chemistry, and manufacture of complex formulations, active pharmaceutical ingredients (APIs) and over-the-counter products. It offers drugs in various dosage forms such as tablets, capsules, injectables, inhalers, ointments, creams and liquids. The company has manufacturing facilities in North America, Latin America, EMEA and Asia Pacific. Sun Pharma is headquartered in Mumbai, Maharashtra, India.

Headquarters India

Address Sun House, Cts No. 201 B/1, Western Exp, Mumbai, 400063


Telephone 91 22 43244324

No of Employees 37,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange SUNPHARMA (NSE)

Revenue (2022) $5.2B

EPS XXX

Market Cap* $24.9B

Net Profit Margin (2021) XXX -24.4%

   

* As of and is in US$

Explore premium data & analytics

990+

Marketed Drugs

Understand Sun Pharmaceutical Industries Ltd’s commercialized product portfolio to stay one step ahead of the market.

600+

Clinical Trials

Determine Sun Pharmaceutical Industries Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

150+

Catalyst Calendar

Proactively evaluate Sun Pharmaceutical Industries Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

130+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Sun Pharmaceutical Industries Ltd’s relevant decision makers and contact details.

40+

Pipeline Drugs

Identify which of Sun Pharmaceutical Industries Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

13+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

9

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

7

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

2

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Product Categories:
Formulations
Active Pharmaceutical Ingredients
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Plans/Strategy In May, the company announced its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing low-density lipoprotein (LDL) cholesterol.
2022 Acquisitions/Mergers/Takeovers In May, the company announced its subsidiary S.C. Terapia S.A acquired the Uractiv portfolio from Fiterman Pharma in Romania.
2022 Regulatory Approval In May, the company received final approval from US FDA for its abbreviated new drug application (ANDA) for generic mesalamine extended release capsules, 500 mg.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Sun Pharmaceutical Industries Ltd Pfizer Inc Novartis AG Sanofi Fresenius SE & Co KGaA
Headquarters India United States of America Switzerland France Germany
City Mumbai New York Basel Paris Bad Homburg Vor Der Hohe
State/Province - New York - - -
No. of Employees 37,000 79,000 110,000 95,442 317,242
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Israel Makov Chairman Executive Board 2012 -
Dilip S. Shanghvi Director; Managing Director Executive Board 2012 66
C. S. Muralidharan Chief Financial Officer Senior Management 2017 -
Sailesh T. Desai Executive Director; Director Executive Board 1999 67
Kalyanasundaram Subramanian Executive Director; Director Executive Board 2017 67
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer